Data depicts friendship between medicine to be held and reduced migraine

In the latest level of the first lesson, a drug received by a drug reduced by children and young people in the annual period.¹

“Migraine’s death compels children and other activities,” Anabea kelleley release by loosing¹ Currently, there are 1 mediine medicine medicine for this age group. Our results are inspiring, showing another zonisamide for migraine attacks. “

Researchers are intended to know if Zonisame Prophlaxis had a headache of heads of headache’s headache for migraine. Zosalide has been used in the Migraine ban in this patient’s residents, but success is not well studied, according to the authors. This lesson was still restraining themselves and included migraine patients using zonseamide. Those who cope with the seizure, they used this medication in less than 6 weeks, or was not neglect from the heads of heads.²

Researchers included 256 patients, and 70% become women, and years of 15 years. Moreover, as a non-successful migraine in 2 or more medications. The consequences shown by, patients were few, patients decreased when heads from 18-month-few days a month. Moreover, patients followed in 2 to six months slowly decreased between 6 elders per month, and the results were in line with the uninvited migraine and migraine.^1,2

“It is very exciting that we can have a successful way to deal with difficulty and young people. However, it is important to note our limitations,” Kelley said the release of the news.¹ For example, our study did not compare people to use medicine to people who do not take care. Next time studies are required in control groups to ensure our fruits. “

Zonsamide was adopted in March 2000 with strengthening capsule as a remedy for adults to adults and epilepsy. After this reception, Zonisamide Oll stopped 100 MG / 5 ML received as adults in 2022 years.^3,4

A new drug request for zonisamide was shipped in March 1997 and originally received a complete response letter before the first permission.³

References

1. The medicine can block migraine attacks to children and young people. The release of the news. A US ACADEMY for Neurology. On March 26, 2024. Found on March 4

2. Kang I, Blizzard S, AkbAich, Kelley, Kelley, Kelley, Kelley W, Kelley, Kelley W, Kelley Academy Academy of last year’s neurology; April 20; San Diego, CA.

3. The food system and drugs. A letter of injections (Zosamide) of approval. NDA 020789. Published on March 10. Found on March 4

4. Biscaldi l. Drug heads. July 2022. Reached by March 4